Sun Pharma Advanced Research Company (SPARC) establishes subsidiary SPARCLIFE Inc. in Delaware, US, according to an exchange filing. SPARCLIFE, Inc., incorporated on September 25, 2023, with 5,000 authorized Common Stock shares valued at USD 0.001 each.
The objective is to utilize SPARCLIFE to manage and oversee global clinical trials through a team of professionals based in the US. Acquisition cost: 50 shares of Common Stock acquired for USD 50,000 in cash.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
